No results for ‘’
Kerala Ayurveda Ltd
₹173.65
(3.53%)
Mon, 14 Sept 2026, 06:57 pm
Health Technology
Pharmaceuticals: Other
24.5KKerala Ayurveda Ratios
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.79 | 17.33 | 21.27 | 32.07 | 31.64 | 28.84 | 9.91 | 0 | 34.94 | 0 | 0 | 0 |
| Price to book ratio | 4.79 | 2.63 | 5.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.09 | 11.24 | 18.92 | 4.87 | 15.93 | 13.50 | 15.78 | 16.85 | 44.51 |
| Price to sales ratio | 5.93 | 2.36 | 2.05 | 0.50 | 1.62 | 2.82 | 1.29 | 1.11 | 0.72 | 1.05 | 1.25 | 1.95 | 1.59 | 1.13 | 0.50 | 0.87 | 1.03 | 0.94 | 2.76 | 3.51 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 7.37 | 0 | 5.31 | 0 | 0 | 0 | 13.33 | 29.99 | 0 | 7.06 | 11.16 | 47.53 | 0 | 17.22 | 0 | 566.14 |
| Enterprise value | 69.41Cr | 76.09Cr | 99.12Cr | 85.12Cr | 113Cr | 133Cr | 95.52Cr | 100Cr | 92.84Cr | 110Cr | 125Cr | 153Cr | 159Cr | 134Cr | 98.26Cr | 115Cr | 151Cr | 160Cr | 341Cr | 493Cr |
| Enterprise value to EBITDA ratio | 177.30 | 133.48 | 0 | 0 | 187.53 | 0 | 298.69 | 34.35 | 28.52 | 18.55 | 17.54 | 20.77 | 17.62 | 27.47 | 11.89 | 53.09 | 13.68 | 26.09 | 39.96 | 0 |
| Debt to equity ratio | 1 | 1.29 | 4.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.11 | 9.51 | 17.72 | 8.10 | 22.77 | 11.45 | 12.99 | 4.08 | 7.44 |
| Return on equity % | 0 | -15 | -64.39 | -375.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 804.69 | 116.41 | 42.04 | 66.90 | -85.51 | 49.64 | -15.41 | -4.62 | -99.18 |
Kerala Ayurveda Ltd Ratios
The Kerala Ayurveda Ltd Ratios page provides a complete fundamental analysis of Kerala Ayurveda Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Kerala Ayurveda Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Kerala Ayurveda Ltd (NSE: , BSE: 530163) is currently trading at ₹173.65, with a market capitalization of ₹226.37Cr. As a major player in the Health technology sector and Pharmaceuticals: other industry, Kerala Ayurveda Ltd remains a key stock for fundamental analysis using Kerala Ayurveda Ltd Ratios.
Kerala Ayurveda Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Kerala Ayurveda Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Kerala Ayurveda Ltd Ratios.
Historically, the Kerala Ayurveda Ltd P/E ratio has shown strong fluctuations:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 34.94
- 2020: 0
The decline in Kerala Ayurveda Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Kerala Ayurveda Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 44.51.
Historical P/B trend:
- 2024: 44.51
- 2023: 16.85
- 2022: 15.78
- 2021: 13.50
Kerala Ayurveda Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Kerala Ayurveda Ltd P/S ratio currently stands at 3.51, an important part of Kerala Ayurveda Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 3.51
- 2023: 2.76
- 2022: 0.94
- 2021: 1.03
The rising Kerala Ayurveda Ltd P/S ratio indicates improved revenue valuation by investors.
Kerala Ayurveda Ltd Price to Cash Flow Ratio (P/CF)
The Kerala Ayurveda Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 566.14.
Historical Kerala Ayurveda Ltd Price to Cash Flow Ratio:
- 2024: 566.14
- 2023: 0
- 2022: 17.22
- 2021: 0
- 2020: 47.53
The rising Kerala Ayurveda Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Kerala Ayurveda Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Kerala Ayurveda Ltd EV currently stands at ₹493Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 493Cr
- 2023: 341Cr
- 2022: 160Cr
- 2021: 151Cr
Kerala Ayurveda Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Kerala Ayurveda Ltd EV/EBITDA ratio is currently 0, a key metric in Kerala Ayurveda Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 0
- 2023: 39.96
- 2022: 26.09
- 2021: 13.68
Stable Kerala Ayurveda Ltd EV/EBITDA indicates balanced valuation.
Kerala Ayurveda Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Kerala Ayurveda Ltd D/E ratio is currently 7.44, reflecting leverage and financial stability.
Historical D/E:
- 2024: 7.44
- 2023: 4.08
- 2022: 12.99
- 2021: 11.45
Higher D/E ratio indicates rising financial risk.
Return on Equity (ROE %)
The Kerala Ayurveda Ltd ROE currently stands at -99.18%, showing profitability and capital efficiency.
Historical ROE:
- 2024: -99.18
- 2023: -4.62
- 2022: -15.41
- 2021: 49.64
Declining ROE indicates pressure on profitability.
Kerala Ayurveda Ltd Ratios Analysis Summary
The Kerala Ayurveda Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Kerala Ayurveda Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Kerala Ayurveda Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.